Literature DB >> 17975019

Prolactin signaling through the short form of its receptor represses forkhead transcription factor FOXO3 and its target gene galt causing a severe ovarian defect.

Julia Halperin1, Y Sangeeta Devi, Sangeeta Y Devi, Shai Elizur, Carlos Stocco, Aurora Shehu, Diane Rebourcet, Terry G Unterman, Nancy D Leslie, Jamie Le, Nadine Binart, Geula Gibori.   

Abstract

Prolactin (PRL) is a hormone with over 300 biological activities. Although the signaling pathway downstream of the long form of its receptor (RL) has been well characterized, little is known about PRL actions upon activation of the short form (RS). Here, we show that mice expressing only RS exhibit an ovarian phenotype of accelerated follicular recruitment followed by massive follicular death leading to premature ovarian failure. Consequently, RS-expressing ovaries of young adults are depleted of functional follicles and formed mostly by interstitium. We also show that activation of RS represses the expression of the transcription factor Forkhead box O3 (FOXO3) and that of the enzyme galactose-1-phosphate uridyltransferase (Galt), two proteins known to be essential for normal follicular development. Our finding that FOXO3 regulates the expression of Galt and enhances its transcriptional activity indicates that it is the repression of FOXO3 by PRL acting through RS that prevents Galt expression in the ovary and causes follicular death. Coexpression of RL with RS prevents PRL inhibition of Galt, and the ovarian defect is no longer seen in RS transgenic mice that coexpress RL, suggesting that RL prevents RS-induced ovarian impairment. In summary, we show that PRL signals through RS and causes, in the absence of RL, a severe ovarian pathology by repressing the expression of FOXO3 and that of its target gene Galt. We also provide evidence of a link between the premature ovarian failure seen in mice expressing RS and in mice with FOXO3 gene deletion as well as in human with Galt mutation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17975019      PMCID: PMC2234584          DOI: 10.1210/me.2007-0399

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  36 in total

1.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

2.  The different forms of the prolactin receptor in the rat corpus luteum: developmental expression and hormonal regulation in pregnancy.

Authors:  C M Telleria; T G Parmer; L Zhong; D L Clarke; C T Albarracin; W R Duan; D I Linzer; G Gibori
Journal:  Endocrinology       Date:  1997-11       Impact factor: 4.736

Review 3.  The molecular control of corpus luteum formation, function, and regression.

Authors:  Carlos Stocco; Carlos Telleria; Geula Gibori
Journal:  Endocr Rev       Date:  2006-10-31       Impact factor: 19.871

Review 4.  Pathophysiology of impaired ovarian function in galactosaemia.

Authors:  T Forges; P Monnier-Barbarino; B Leheup; P Jouvet
Journal:  Hum Reprod Update       Date:  2006-07-11       Impact factor: 15.610

Review 5.  FOXO transcription factors at the interface between longevity and tumor suppression.

Authors:  Eric L Greer; Anne Brunet
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

6.  LS14: a novel human adipocyte cell line that produces prolactin.

Authors:  Eric R Hugo; Terry D Brandebourg; Clay E S Comstock; Keith S Gersin; Jeffrey J Sussman; Nira Ben-Jonathan
Journal:  Endocrinology       Date:  2005-09-29       Impact factor: 4.736

7.  Suppression subtractive hybridization (SSH) identifies prolactin stimulation of p38 MAP kinase gene expression in Nb2 T lymphoma cells: molecular cloning of rat p38 MAP kinase.

Authors:  E Nemeth; C Bole-Feysot; L S Tashima
Journal:  J Mol Endocrinol       Date:  1998-02       Impact factor: 5.098

8.  Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a.

Authors:  Lian Liu; Singareddy Rajareddy; Pradeep Reddy; Chun Du; Krishna Jagarlamudi; Yan Shen; David Gunnarsson; Gunnar Selstam; Karin Boman; Kui Liu
Journal:  Development       Date:  2007-01       Impact factor: 6.868

9.  Correlation between FOXO1a (FKHR) and FOXO3a (FKHRL1) binding and the inhibition of basal glucose-6-phosphatase catalytic subunit gene transcription by insulin.

Authors:  Hiroshi Onuma; Beth T Vander Kooi; Jared N Boustead; James K Oeser; Richard M O'Brien
Journal:  Mol Endocrinol       Date:  2006-07-13

Review 10.  Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.

Authors:  C Bole-Feysot; V Goffin; M Edery; N Binart; P A Kelly
Journal:  Endocr Rev       Date:  1998-06       Impact factor: 19.871

View more
  16 in total

1.  The long and short of the prolactin receptor: the corpus luteum needs them both!

Authors:  Carlos Stocco
Journal:  Biol Reprod       Date:  2012-03-22       Impact factor: 4.285

2.  Regulation of transcription factors and repression of Sp1 by prolactin signaling through the short isoform of its cognate receptor.

Authors:  Y Sangeeta Devi; Aurora Shehu; Carlos Stocco; Julia Halperin; Jamie Le; Anita M Seibold; Michal Lahav; Nadine Binart; Geula Gibori
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

3.  Prolactin activation of the long form of its cognate receptor causes increased visceral fat and obesity in males as shown in transgenic mice expressing only this receptor subtype.

Authors:  J A Le; H M Wilson; A Shehu; Y S Devi; T Aguilar; G Gibori
Journal:  Horm Metab Res       Date:  2011-10-11       Impact factor: 2.936

4.  Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase.

Authors:  Y Sangeeta Devi; Anita M Seibold; Aurora Shehu; Evelyn Maizels; Julia Halperin; Jamie Le; Nadine Binart; Lei Bao; Geula Gibori
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

5.  Generation of mice expressing only the long form of the prolactin receptor reveals that both isoforms of the receptor are required for normal ovarian function.

Authors:  Jamie A Le; Heather M Wilson; Aurora Shehu; Jifang Mao; Y Sangeeta Devi; Julia Halperin; Tetley Aguilar; Anita Seibold; Evelyn Maizels; Geula Gibori
Journal:  Biol Reprod       Date:  2012-03-22       Impact factor: 4.285

6.  Subfertility and growth restriction in a new galactose-1 phosphate uridylyltransferase (GALT) - deficient mouse model.

Authors:  Manshu Tang; Anwer Siddiqi; Benjamin Witt; Tatiana Yuzyuk; Britt Johnson; Nisa Fraser; Wyman Chen; Rafael Rascon; Xue Yin; Harish Goli; Olaf A Bodamer; Kent Lai
Journal:  Eur J Hum Genet       Date:  2014-02-19       Impact factor: 4.246

7.  Biomarkers of ovarian function in girls and women with classic galactosemia.

Authors:  Rebecca D Sanders; Jessica B Spencer; Michael P Epstein; Susan V Pollak; Pratibhasri A Vardhana; Joyce W Lustbader; Judith L Fridovich-Keil
Journal:  Fertil Steril       Date:  2008-08-05       Impact factor: 7.329

Review 8.  Genomic markers of ovarian reserve.

Authors:  Michelle A Wood; Aleksandar Rajkovic
Journal:  Semin Reprod Med       Date:  2013-10-07       Impact factor: 1.303

9.  Beclin-1 deficiency in the murine ovary results in the reduction of progesterone production to promote preterm labor.

Authors:  Thomas R Gawriluk; CheMyong Ko; Xiaoman Hong; Lane K Christenson; Edmund B Rucker
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

10.  Prolactin signaling through the short isoform of the mouse prolactin receptor regulates DNA binding of specific transcription factors, often with opposite effects in different reproductive issues.

Authors:  Y Sangeeta Devi; Aurora Shehu; Julia Halperin; Carlos Stocco; Jamie Le; Anita M Seibold; Geula Gibori
Journal:  Reprod Biol Endocrinol       Date:  2009-08-24       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.